Message-ID: <14948561.1075860677355.JavaMail.evans@thyme>
Date: Tue, 5 Jun 2001 12:21:00 -0700 (PDT)
From: showard@agsk.com
To: richard.b.sanders@enron.com, wcp@quinnemanuel.com
Subject: Fwd: RE: Hellmold
Mime-Version: 1.0
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: 7bit
X-From: showard@agsk.com
X-To: Richard.B.Sanders@enron.com, wcp@quinnemanuel.com
X-cc: 
X-bcc: 
X-Folder: \Richard_Sanders_Jun2001\Notes Folders\Notes inbox
X-Origin: Sanders-R
X-FileName: rsander.nsf

See below.  The settlement figures that I gave you last week ($13 million v.
"high 20s") were for Farallon and Oaktree together, but NOT Legg Mason. 
Farallon's damages are about 62% of the Farallon/Oaktree total, so it appears
that Hennigan is looking for around $17 million to settle Farallon
                                                                              
                                                                              
                                                                              
                                                                              
                                                                              
                                                                              
                             ................................................

ALSCHULER GROSSMAN STEIN & KAHAN LLP
ATTORNEYS AT LAW
www.agsk.com

2049 Century Park East
Thirty-Ninth Floor
Los Angeles, CA 90067-3213
Tel 310-277-1226
Fax 310-552-6077

This transmission is intended only for the use
of the addressee and may contain information
that is privileged, confidential and exempt from
disclosure under applicable law. If you are not
the intended recipient, or the employee or agent
responsible for delivering the message to the
intended recipient, you are hereby notified that
any dissemination, distribution or copying of
this communication is strictly prohibited.

If you have received this communication
in error, please notify us immediately
via e-mail at postmaster@agsk.com or
by telephone at 310-277-1226. Thank you.

...............................................
 - Enclosed.txt
 - ALTERNATIVE.HTM